Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and PK Study of AZD7594 in Healthy Subjects
NCT04002427Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2019
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of velsecorat in asthma, sponsored by AstraZeneca. Primary endpoints: Amount Excreted, Fraction Excreted and 3 more. Started Jun 2019; status: completed.
02
Drugs
velsecorat
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04002427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002427.